Results 141 to 150 of about 37,774 (258)

O4‐09‐04: Reduced regional cortical thickness rate of change in donepezil‐treated subjects with suspected prodromal Alzheimer's disease: A longitudinal, multi‐centric, double‐blind, randomized, placebo‐controlled trial [PDF]

open access: bronze, 2015
Enrica Cavedo   +26 more
openalex   +1 more source

Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis

open access: yesClinical Interventions in Aging, 2008
Richard A Hansen1, Gerald Gartlehner2, Aaron P Webb1, Laura C Morgan3, Charity G Moore4, Daniel E Jonas31School of Pharmacy, 3Cecil G Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, NC, USA; 2Department for Evidence ...
Richard A Hansen   +5 more
doaj  

From bench to brain: novel thieno-oxazine hybrids as potent pleiotropic anti-Alzheimer's agents with <i>in vivo</i>/<i>in vitro</i> validation and <i>in silico</i> insights. [PDF]

open access: yesJ Enzyme Inhib Med Chem
Fayed EA   +13 more
europepmc   +1 more source

Design, Synthesis, and Biological Evaluation of Novel Acetylcholinesterase and β-Secretase 1 Inhibitors. [PDF]

open access: yesInt J Mol Sci
Drozdowska D   +8 more
europepmc   +1 more source

Long-Term Effects Of Combined Treatment With Memantine And Donepezil On Alzheimer's Disease Patients: 72-Week Study [PDF]

open access: bronze, 2018
Rei Wake   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy